These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 38947969)

  • 1. Sarcopenic obesity in patients awaiting liver transplant: Unique challenges for nutritional recommendations.
    Herscovici DM; Cooper KM; Colletta A; Rightmyer M; Shingina A; Feld LD
    World J Transplant; 2024 Jun; 14(2):90202. PubMed ID: 38947969
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nonalcoholic steatohepatitis is strongly associated with sarcopenic obesity in patients with cirrhosis undergoing liver transplant evaluation.
    Carias S; Castellanos AL; Vilchez V; Nair R; Dela Cruz AC; Watkins J; Barrett T; Trushar P; Esser K; Gedaly R
    J Gastroenterol Hepatol; 2016 Mar; 31(3):628-33. PubMed ID: 26399838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Association between Dietary Habits and Sarcopenia in Patients with Liver Cirrhosis.
    Topan MM; Sporea I; Dănilă M; Popescu A; Ghiuchici AM; Lupușoru R; Șirli R
    J Clin Med; 2023 Jul; 12(14):. PubMed ID: 37510811
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sarcopenic obesity with metabolic syndrome: a newly recognized entity following living donor liver transplantation.
    Choudhary NS; Saigal S; Saraf N; Mohanka R; Rastogi A; Goja S; Menon PB; Mishra S; Mittal A; Soin AS
    Clin Transplant; 2015 Mar; 29(3):211-5. PubMed ID: 25594826
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CT-quantified sarcopenic visceral obesity is associated with poor transplant waitlist mortality in patients with cirrhosis.
    Ha NB; Fan B; Shui AM; Huang CY; Brandman D; Lai JC
    Liver Transpl; 2023 May; 29(5):476-484. PubMed ID: 36735830
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Research progress of sarcopenic obesity and chronic liver disease].
    Tang LY; Zhou LZ; Zhang P
    Zhonghua Gan Zang Bing Za Zhi; 2023 Apr; 31(4):445-448. PubMed ID: 37248986
    [TBL] [Abstract][Full Text] [Related]  

  • 7. SARCOPENIA, OBESITY AND SARCOPENIC OBESITY IN LIVER TRANSPLANTATION: A BODY COMPOSITION PROSPECTIVE STUDY.
    Anastácio LR; Ferreira LG; Ribeiro HS; Diniz KGD; Lima AS; Correia MITD; Vilela EG
    Arq Bras Cir Dig; 2019; 32(2):e1434. PubMed ID: 31038559
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Body composition and the skeletal muscle compartment in liver transplantation: Turning challenges into opportunities.
    Reichelt S; Pratschke J; Engelmann C; Neumann UP; Lurje G; Czigany Z
    Am J Transplant; 2022 Aug; 22(8):1943-1957. PubMed ID: 35523584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Radiological Quantification of Sarcopenic Obesity and its Role in Chronic Liver Disease Severity.
    Cimsit C; Kursun M; Demircioglu O; Dilber F; Demirtas CO; Ergenc I
    Acad Radiol; 2023 Sep; 30 Suppl 1():S124-S131. PubMed ID: 37012127
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Novel approaches to sarcopenic obesity and weight management before and after kidney transplantation.
    Tantisattamo E; Kalantar-Zadeh K; Halleck F; Duettmann W; Naik M; Budde K
    Curr Opin Nephrol Hypertens; 2021 Jan; 30(1):14-26. PubMed ID: 33186218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sarcopenic visceral obesity is associated with increased post-liver transplant mortality in acutely ill patients with cirrhosis.
    Ha NB; Montano-Loza AJ; Carey EJ; Lin S; Shui AM; Huang CY; Dunn MA; Lai JC
    Am J Transplant; 2022 Sep; 22(9):2195-2202. PubMed ID: 35486028
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myosteatosis, the More Significant Predictor of Outcome: An Analysis of the Impact of Myosteatosis, Sarcopenia, and Sarcopenic Obesity on Liver Transplant Outcomes in Johannesburg, South Africa.
    Irwin NEA; Fabian J; Hari KR; Lorentz L; Mahomed A; Botha JF
    Exp Clin Transplant; 2021 Sep; 19(9):948-955. PubMed ID: 34387151
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Sarcopenic obesity and myosteatosis are associated with higher mortality in patients with cirrhosis.
    Montano-Loza AJ; Angulo P; Meza-Junco J; Prado CM; Sawyer MB; Beaumont C; Esfandiari N; Ma M; Baracos VE
    J Cachexia Sarcopenia Muscle; 2016 May; 7(2):126-35. PubMed ID: 27493866
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Mini Nutritional Assessment combined with body fat for detecting the risk of sarcopenia and sarcopenic obesity in metabolic syndrome.
    Yen CH; Lee YW; Chang WJ; Lin PT
    Br J Nutr; 2024 May; 131(10):1659-1667. PubMed ID: 38312003
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Exercise and Nutrition Strategies to Counteract Sarcopenic Obesity.
    Trouwborst I; Verreijen A; Memelink R; Massanet P; Boirie Y; Weijs P; Tieland M
    Nutrients; 2018 May; 10(5):. PubMed ID: 29757230
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nutrition and the transplant candidate.
    Mazurak VC; Tandon P; Montano-Loza AJ
    Liver Transpl; 2017 Nov; 23(11):1451-1464. PubMed ID: 29072825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of sarcopenic overweight on the outcomes after living donor liver transplantation.
    Hammad A; Kaido T; Hamaguchi Y; Okumura S; Kobayashi A; Shirai H; Kamo N; Yagi S; Uemoto S
    Hepatobiliary Surg Nutr; 2017 Dec; 6(6):367-378. PubMed ID: 29312971
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Sarcopenic obesity in cirrhosis-The confluence of 2 prognostic titans.
    Eslamparast T; Montano-Loza AJ; Raman M; Tandon P
    Liver Int; 2018 Oct; 38(10):1706-1717. PubMed ID: 29738109
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Shining a spotlight on sarcopenia and myosteatosis in liver disease and liver transplantation: Potentially modifiable risk factors with major clinical impact.
    Reichelt S; Merle U; Klauss M; Kahlert C; Lurje G; Mehrabi A; Czigany Z
    Liver Int; 2024 Jul; 44(7):1483-1512. PubMed ID: 38554051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sarcopenic Obesity Versus Nonobese Sarcopenia in Hemodialysis Patients: Differences in Nutritional Status, Quality of Life, and Clinical Outcomes.
    Beberashvili I; Azar A; Khatib A; Abu Hamad R; Neheman A; Efrati S; Doenyas-Barak K
    J Ren Nutr; 2023 Jan; 33(1):147-156. PubMed ID: 35597322
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.